<DOC>
<DOCNO>
EP-0017469
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
C07H-15/252 C07H-17/02 C07D-333/74 C07D-333/00 C07D-333/64 C07H-15/00 C07D-333/38 C07D-333/50 C07H-17/00 
</IPC-CLASSIFICATIONS>
<TITLE>
novel heterocyclic anthracycline compounds, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
kende andrew stevenus<sep>newman howardus<sep>kende, andrew steven<sep>newman, howard <sep>kende, andrew steven 19 larchwood drivepittsford new yorkus<sep>newman, howard11 kuperman lanemonsey new yorkus<sep>
</APPLICANT>
<INVENTOR>
kende andrew steven<sep>kende, andrew steven<sep>kende, andrew steven19 larchwood drivepittsford new yorkus<sep>newman, howard11 kuperman lanemonsey new yorkus<sep>
</INVENTOR>
<ABSTRACT>
there are disclosed novel heterocyclic anthracycline  compounds having antitumor activity against murine p388  leukemia in mice, processes for preparing the novel comÂ­ pounds and pharmaceutical compositions containing them.   the novel compounds have the formula:    wherein r is hydrogen or hydroxy and x, y or z may be  sulfur with the proviso that when x is sulfur then y and z are  both ch and when y is sulfur then x and z are both ch and  when z is sulfur then x and y are both ch, or the formula:  
</ABSTRACT>
</TEXT>
</DOC>
